×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
LS20 Open Innovation in Drug Development in Japan: Preparations in Normal Times, Challenges, and Practices
Session Chair(s)
Makoto Nagaoka, PhD
Head of Regulatory Affairs, Japan
BeiGene Japan, Japan
Speaker(s)
Kotone Matsuyama, RPh
Kotone Matsuyama, RPh
Nippon Medical School, Japan
Professor, Department of Health Policy and Management
Keiichi Fukuda, MD, PhD
Keiichi Fukuda, MD, PhD
Graduate School of Medicine, Keio University, Japan
Professor, Department of Regenerative Medicine and Advanced Cardiac Therapeutics
Noriatsu Kono, MPharm
Noriatsu Kono, MPharm
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Organizational management
Liu Lei
Liu Lei
AstraZeneca K.K., Japan
Innovation Partnerships & i2.JP Director